InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.18
(
-0.34%
)
Bitcoin
60,773.66
(
-0.06%
)
Post# of 252388
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

apljack

Send PM Follow Ignore
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

apljack

Re: None

Tuesday, 10/29/2019 9:57:00 AM

Tuesday, October 29, 2019 9:57:00 AM

Post# of 252388
NEO Beats on revenue estimates by $5+ million, earnings of 7c/share (GAAP, in line with estimates) and is hitting on all cylinders.
Third-Quarter Highlights:

Consolidated revenue increased 51% to $104.7 million
Clinical Services revenue increased 56% to $92.6 million
Pharma Services revenue increased 26% to $12.1 million
Pharma Services backlog increased 22% to $118.3 million
Gross profit increased 57% to $50.8 million
Full-year 2019 guidance increased

The company has revised revenue estimates up (again), and hs solid earnings profile.

https://finance.yahoo.com/news/neogenomics-reports-51-revenue-growth-110000433.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up